Cytori completes enrollment for breast augmentation study in Japan

This independent, investigator-initiated study is being sponsored by Tatsuro Kamakura, chief medical officer of Cosmetic Surgery Seishin, in Japan. Results of the study will be available following a nine month assessment of the primary endpoints of cosmetic improvement and volume retention.

Mr Kamakura, said: “Our clinic’s goal for this study was to learn if cell-enhanced reconstruction is feasible for bilateral cosmetic breast augmentation as an alternative to implants. We look forward to assessing the procedure’s effect on volume retention following the nine-month follow-up period as we believe that cell-enhanced reconstruction could overcome the challenges often associated with conventional, non-cell-enhanced fat grafting. We plan to continue offering cell-enhanced reconstruction to our patients in Tokyo and expand it to patients in our Osaka clinic as well.”